Correlation Between Verrica Pharmaceuticals and Viracta Therapeutics
Can any of the company-specific risk be diversified away by investing in both Verrica Pharmaceuticals and Viracta Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Verrica Pharmaceuticals and Viracta Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Verrica Pharmaceuticals and Viracta Therapeutics, you can compare the effects of market volatilities on Verrica Pharmaceuticals and Viracta Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Verrica Pharmaceuticals with a short position of Viracta Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Verrica Pharmaceuticals and Viracta Therapeutics.
Diversification Opportunities for Verrica Pharmaceuticals and Viracta Therapeutics
0.66 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Verrica and Viracta is 0.66. Overlapping area represents the amount of risk that can be diversified away by holding Verrica Pharmaceuticals and Viracta Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Viracta Therapeutics and Verrica Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Verrica Pharmaceuticals are associated (or correlated) with Viracta Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Viracta Therapeutics has no effect on the direction of Verrica Pharmaceuticals i.e., Verrica Pharmaceuticals and Viracta Therapeutics go up and down completely randomly.
Pair Corralation between Verrica Pharmaceuticals and Viracta Therapeutics
Given the investment horizon of 90 days Verrica Pharmaceuticals is expected to generate 1.06 times more return on investment than Viracta Therapeutics. However, Verrica Pharmaceuticals is 1.06 times more volatile than Viracta Therapeutics. It trades about 0.01 of its potential returns per unit of risk. Viracta Therapeutics is currently generating about -0.05 per unit of risk. If you would invest 306.00 in Verrica Pharmaceuticals on September 2, 2024 and sell it today you would lose (178.00) from holding Verrica Pharmaceuticals or give up 58.17% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Verrica Pharmaceuticals vs. Viracta Therapeutics
Performance |
| Timeline |
| Verrica Pharmaceuticals |
| Viracta Therapeutics |
Verrica Pharmaceuticals and Viracta Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Verrica Pharmaceuticals and Viracta Therapeutics
The main advantage of trading using opposite Verrica Pharmaceuticals and Viracta Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Verrica Pharmaceuticals position performs unexpectedly, Viracta Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Viracta Therapeutics will offset losses from the drop in Viracta Therapeutics' long position.The idea behind Verrica Pharmaceuticals and Viracta Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
| Viracta Therapeutics vs. Tff Pharmaceuticals | Viracta Therapeutics vs. Eliem Therapeutics | Viracta Therapeutics vs. Inhibrx | Viracta Therapeutics vs. Enliven Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Other Complementary Tools
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges |